- Home
- MSM vs ACLX Comparison
MSM vs ACLX Comparison
Compare MSM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSM | ACLX |
|---|---|---|
| Founded | 1941 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.2B |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MSM | ACLX |
|---|---|---|
| Price | $86.31 | $72.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $91.25 | ★ $115.71 |
| AVG Volume (30 Days) | 679.0K | ★ 1.4M |
| Earning Date | 01-07-2026 | 11-05-2025 |
| Dividend Yield | ★ 4.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.57 | N/A |
| Revenue | ★ $3,769,521,000.00 | $35,898,000.00 |
| Revenue This Year | $6.46 | N/A |
| Revenue Next Year | $5.08 | $302.49 |
| P/E Ratio | $24.30 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $68.10 | $47.86 |
| 52 Week High | $94.31 | $94.07 |
Technical Indicators
Market Signals| Indicator | MSM | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 52.48 | 40.25 |
| Support Level | $81.04 | $68.64 |
| Resistance Level | $89.92 | $73.98 |
| Average True Range (ATR) | 2.22 | 5.77 |
| MACD | 0.09 | -0.14 |
| Stochastic Oscillator | 61.30 | 21.95 |
Price Performance
Historical ComparisonAbout MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.